• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neurol Sci . Limited evidence for neuropsychological dysfunction in patients initially affected by severe COVID-19

tetano

Editor, Senior Moderator
Neurol Sci


. 2022 Sep 2.
doi: 10.1007/s10072-022-06373-5. Online ahead of print.
Limited evidence for neuropsychological dysfunction in patients initially affected by severe COVID-19


Konstantinos Priftis[SUP] 1 2 [/SUP], Valeria Velardo[SUP] 3 [/SUP], Matteo Giuseppe Felice Vascello[SUP] 3 [/SUP], Stella Villella[SUP] 3 [/SUP], Silvia Galeri[SUP] 3 [/SUP], Maria Simonetta Spada[SUP] 4 [/SUP], Lorella Algeri[SUP] 3 [/SUP]



Affiliations

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), resulting in coronavirus disease 2019 (COVID-19), has caused a pandemic. There is now considerable evidence that neuropsychological functions could be affected. We further tested this hypothesis on a sample of post COVID-19 patients, who, initially, had been severely affected.
Methods: We tested 22 post COVID-19 patients who, after the intensive care unit (all but one), were admitted to our rehabilitation unit to be treated for severe post COVID-19 sequelae. All patients were administered a comprehensive neuropsychological battery including measures assessing perceptual, attentive, mnestic, linguistic, and executive functions, and overall cognitive status. The patients were also administered rehabilitation measures including scales for investigating aerobic capacity/endurance deficits, dyspnea, and fatigue.
Results: Our findings revealed that evidence of neuropsychological disorders in post COVID-19 patients was very limited. Furthermore, COVID-19 severity and other relevant variables were not correlated with patients' scores on the neuropsychological tests.
Conclusions: We suggest that the relation between COVID-19 and neuropsychological disorders is unclear. New studies and metanalyses are highly required to shed light on this highly complex issue.

Keywords: COVID-19; Neuropsychological assessment; Neuropsychology; SARS-CoV-2.
 
Back
Top Bottom